IGF-1 LR3 (1mg) Lyophilised Research Material

IGF-1 LR3 is a long-acting analogue of insulin-like growth factor-1 supplied in lyophilised (freeze-dried) powder form for laboratory research purposes.

IGF-1 LR3 differs structurally from native IGF-1 due to an arginine substitution at position 3 and an extended amino acid sequence, which increases its stability in experimental settings. It is commonly utilised in in-vitro and preclinical research models investigating cellular growth signalling pathways.

Product Specifications

• Peptide: IGF-1 LR3
• Purity: ≥98% (HPLC tested)
• Format: Lyophilised powder
• Quantity: 1mg per sterile vial
• Appearance: White/off-white powder
• Storage: Store refrigerated at 2–8°C. For extended storage, keep frozen.
• Reconstitution: For laboratory use with sterile bacteriostatic water under controlled research conditions.

Research Context

Published experimental literature has explored IGF-1 LR3 in relation to:

• Cellular growth signalling pathways
• Receptor binding and activation models
• Protein synthesis mechanisms (laboratory studies)
• Tissue culture proliferation research

These observations are limited to controlled laboratory and experimental environments.

Important Notice

• For research use only.
• Not for human consumption.
• Not intended to diagnose, treat, cure, or prevent any disease.
• Not a medicinal product.
• Must be handled by qualified professionals in a licensed research setting.

Klarity supplies peptides exclusively for laboratory and analytical research purposes.